U.S. FDA Launches Operation Stork Speed to Enhance Infant Formula Safety and Quality
On March 18, 2025, the U.S. Departmzinc citrate tabletent of Health and Human Services (HHS) announced that it would lead the Food and Drug Administration (FDA) in imagnesium citrate bone healthmplemmagnesium malate citrat
eenting new measures to enhance the quality, safety, nutritional adequa
cychewable calcium citrate with vitamin d, and supply rcalcium citrate malate magnesium zinc and vitamin d3esilience of infant formula in the United States.